17
a
Schedules were those recommended as antiemetic drug doses as of October 4, 2016. Prices per
dose were for a single infusion or per pill for orally administered medications. Prices for infused
drugs reimbursed through Medicare Part B only were identified from the 2016 Medicare Part B
Drug Average Sales Price Data (https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Part-B-
Drugs/McrPartBDrugAvgSalesPrice/index.html). Prices for orally administered drugs reimbursed
through Medicare Part D were identified in the PlanFinder for a beneficiary living within ZIP
code 10065 (www.medicare.gov). To remain as consistent as possible with prior methodolog y, we
selected a Humana PDP plan with the lowest cost for beneficiaries to identify the full cost of each
drug (Bach PB. Limits on Medicare's ability to control rising spending on cancer drugs. e New
England Journal of Medicine. 2009;360(6):626-33. AND https://www.mskcc.org/sites/default/
files/node/25097/documents/methods-for-drug-price-calculations-12.9.15.pdf ). Drug costs
may vary by plan and by pharmacy where a prescription is filled (eg, preferred or nonpreferred
pharmacies). In some cases, antiemetic coverage for orally administered drugs may be covered by
either Part B or Part D. We have selected the Medicare Part D price in these cases. Note: drug
prices are dynamic and the prices listed in the table may not reflect current prices. In some cases,
the recorded out-of-pocket price per dose is equivalent to the price per cycle. is may represent a
minimum price per fill set by the health plan.
b
Price information not yet available through Medicare.
c
Assume 3 days use, 12 pills per day.
Table 6. Estimated Costs for Antiemetic Products
a
Footnotes
